medigraphic.com
SPANISH

Revista Mexicana de Medicina Física y Rehabilitación

ISSN 1405-8790 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 3-4

<< Back

Rev Mex Med Fis Rehab 2020; 32 (3-4)

Health care outcomes for children diagnosed with autism spectrum disorder after entering the Naval Medical Center's Pediatric Rehabilitation Program. Qualitative study

Castillo FTJ, Martínez LLE, Sánchez AA
Full text How to cite this article 10.35366/101972

DOI

DOI: 10.35366/101972
URL: https://dx.doi.org/10.35366/101972

Language: Spanish
References: 19
Page: 62-70
PDF size: 281.60 Kb.


Key words:

Autism spectrum disorder, sensory integration therapy, diagnostic and statistical manual of mental disorders.

ABSTRACT

Autism spectrum disorder is a complex neurodevelopmental disorder, with a high incidence that currently represents an especially important public health problem, having a prevalence of approximately 1 in 168 children according to the WHO, and reporting a higher prevalence in sex male compared to female. The high incidence and symptoms of this condition cause difficulties on a personal, family and social level. Objectives: To evaluate the results obtained in children with a diagnosis of autism spectrum disorder, in the areas of adaptation, communication and cognition after receiving sensory integration therapy in the Pediatric Rehabilitation Program, to give a diagnosis and treatment of timely manner improves the quality of life of these patients. Material and methods: A review of the files of the children with autism spectrum disorder, who met the inclusion criteria, was performed, data were analyzed regarding the improvement in the areas of adaptation, communication, and cognition according to the progress reported by the parents after admission to the Pediatric Rehabilitation Program. Conclusions: Improvement was found in the areas of adaptation, communication, and cognition in all children with autism spectrum disorder.


REFERENCES

  1. Baum SH, Stevenson RA, Wallace MT. Behavioral, perceptual, and neural alterations in sensory and multisensory function in autism spectrum disorder. Prog Neurobiol. 2015; 134: 140-60.

  2. Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015; 14 (11): 1109-1120.

  3. Diagnóstico y manejo de los trastornos del espectro autista. México: Secretaría de Salud; 2012.

  4. Ferri SL, Abel T, Brodkin ES. Sex differences in autism spectrum disorder: a review. Curr Psychiatry Rep. 2018; 20 (2): 9.

  5. Woodbury-Smith M, Scherer SW. Progress in the genetics of autism spectrum disorder. Dev Med Child Neurol. 2018; 60 (5): 445-451.

  6. Wi?niowiecka-Kowalnik B, Nowakowska BA. Genetics and epigenetics of autism spectrum disorder-current evidence in the field. J Appl Genet. 2019; 60 (1): 37-47.

  7. Oviedo N, Manuel-Apolinar L, De la Chesnaye E, Guerra-Araiza C. Aspectos genéticos y neuroendocrinos en el trastorno del espectro autista. Bol Med Hosp Infant Mex. 2015; 72 (1): 5-14.

  8. Posar A, Visconti P. Sensory abnormalities in children with autism spectrum disorder. J Pediatr (Rio J). 2018; 94 (4): 342-350.

  9. Fezer GF, Matos MB, Nau AL, Zeigelboim BS, Marques JM, Liberalesso PBN. Perinatal features of children with autism spectrum disorder. Rev Paul Pediatr. 2017; 35 (2): 130-135.

  10. Thye MD, Bednarz HM, Herringshaw AJ, Sartin EB, Kana RK. The impact of atypical sensory processing on social impairments in autism spectrum disorder. Dev Cogn Neurosci. 2018; 29: 151-167.

  11. Bjorklund G, Saad K, Chirumbolo S, Kern JK, Geier DA, Geier MR et al. Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiol Exp (Wars). 2016; 76 (4): 257-268.

  12. Edmiston E, Ashwood P, Van de Water J. Autoimmunity, autoantibodies, and autism spectrum disorder. Biol Psychiatry. 2017; 81 (5): 383-390.

  13. Meltzer A, Van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology. 2017; 42 (1): 284-298.

  14. Posar A, Visconti P. Autism in 2016: the need for answers. J Pediatr (Rio J). 2017; 93 (2): 111-119.

  15. Pav?l D. A Dopamine hypothesis of autism spectrum disorder. Dev Neurosci. 2017; 39 (5): 355-360.

  16. Dan B. Very early diagnosis of autism spectrum disorder. Dev Med Child Neurol. 2018; 60 (11): 1066.

  17. Coury DL. DSM-5 and autism spectrum disorders: implications for families and clinicians. J Dev Behav Pediatr. 2013; 34 (7): 494-496.

  18. Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, et al. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018; 32 (1): 3-29.

  19. Xu W, Yao J, Liu W. Intervention effect of sensory integration training on the behaviors and quality of life of children with autism. Psychiatr Danub. 2019; 31 (3): 340-346.




Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Table 1
Table 2

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Med Fis Rehab. 2020;32